Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA - Multiple System Atrophy”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Not applicableStudy completedNCT06221644
What this trial is testing

Synapse Alterations in MSA Patients

Who this might be right for
Multiple System Atrophy
Xiangya Hospital of Central South University 90
Early research (Phase 1)Study completedNCT05638620
What this trial is testing

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

Who this might be right for
Post Acute COVID-19 SyndromeLong COVIDLong Covid19+12 more
Jonathann Kuo, MD 20
Not applicableLooking for participantsNCT07392411
What this trial is testing

Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers

Who this might be right for
Parkinson's DiseaseProgressive Supranuclear Palsy(PSP)Multiple System Atrophy+1 more
Beijing Tiantan Hospital 720
Not applicableStudy completedNCT04495582
What this trial is testing

Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)

Who this might be right for
Multiple System Atrophy
Corestemchemon, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00202397
What this trial is testing

Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

Who this might be right for
Hereditary AtaxiaMultiple SclerosisCerebellar Ataxia
S. Andrea Hospital 40
Large-scale testing (Phase 3)Study completedNCT02008721
What this trial is testing

Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach

Who this might be right for
Multiple System Atrophy
Dr. Johannes Levin 92
Testing effectiveness (Phase 2)Looking for participantsNCT06568237
What this trial is testing

Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study

Who this might be right for
Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D LLC 200
Not applicableNot Yet RecruitingNCT07036939
What this trial is testing

Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Ruijin Hospital 46
Not applicableEnrolling By InvitationNCT07081841
What this trial is testing

AB-1005 Long-Term Follow-up Study

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy, Parkinson Variant
AskBio Inc 132
Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Not applicableStudy completedNCT01044992
What this trial is testing

Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

Who this might be right for
Multisystemic Atrophy
University Hospital, Toulouse 38
Early research (Phase 1)Looking for participantsNCT06683365
What this trial is testing

Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

Who this might be right for
Multiple System AtrophyParkinsons Disease
Craig van Horne, MD, PhD 7
Not applicableUnknownNCT03721887
What this trial is testing

Exploit the Neural Source and the Feasibility of Transcranial Direct Current Stimulation for Freezing of Gait in Parkinson's Disease and Multiple System Atrophy

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy
China Medical University Hospital 40
Large-scale testing (Phase 3)Study completedNCT02071459
What this trial is testing

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

Who this might be right for
Multiple System Atrophy
University Hospital, Toulouse 107
Not applicableStudy completedNCT05889260
What this trial is testing

Speech Accessibility Project

Who this might be right for
Parkinson DiseaseProgressive Supranuclear PalsyMultiple System Atrophy+1 more
University of Illinois at Urbana-Champaign 485
Not applicableStudy completedNCT01485549
What this trial is testing

Oligomeric Alpha-synuclein in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
University Hospital, Bordeaux 48
Not applicableStudy completedNCT05638815
What this trial is testing

An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy
SciNeuro 89
Not applicableUnknownNCT04617873
What this trial is testing

DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism

Who this might be right for
Multiple System Atrophy, Parkinson Variant (Disorder)
zhangyuqing 20
Load More Results